🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of study is to compare bladder intact-event free survival (BI-E...
Status
Active Not Recruiting
Location
Loma Linda Univ Faculty Medic
Start Date
2020-12-07
Trial ID
NCT04658862
The purpose of this study is to determine the safety, feasibility, recommen...
Status
Recruiting
Location
NYU Langone Health
Start Date
2024-04-10
Trial ID
NCT06311578
Treatments Being Tested
The Primary purpose of this study is to identify the recommended Phase 2 do...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2016-11-21
Trial ID
NCT02908906
Treatments Being Tested
Erdafitinib (ERDA) alone or in combination with cetrelimab (CET) as neoadju...
Status
Recruiting
Location
CLCC Jean Perrin
Start Date
2023-03-07
Trial ID
NCT06511648
Treatments Being Tested
The purpose of this study is to: a) establish the recommended phase 2 dose ...
Status
Active Not Recruiting
Location
Urological Associates of Southern Arizona, P.C.
Start Date
2018-03-02
Trial ID
NCT03431350
Treatments Being Tested
The purpose of this study is to evaluate the anti-tumor effects of TAR-200 ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2022-07-07
Trial ID
NCT04919512
Treatments Being Tested
This phase II trial studies the effect of cabazitaxel, carboplatin, and cet...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-12-29
Trial ID
NCT04592237
Treatments Being Tested
The primary purpose of this study is to identify the recommended Phase 2 do...
Status
Completed
Location
National Cancer Center Hospital
Start Date
2018-08-31
Trial ID
NCT03547037
Treatments Being Tested
The purpose of this study is to identify the recommended phase 2 regimen(s)...
Status
Recruiting
Location
Florida Cancer Specialists
Start Date
2023-04-26
Trial ID
NCT05818683
The purpose of Part 1 of this study is to determine a safe, tolerable, and ...
Status
Recruiting
Location
Mayo Clinic in Florida
Start Date
2026-05-18
Trial ID
NCT07525141
Treatments Being Tested